DeepGene damage signature
SyntheticSynthetic demo data2 samples: baseline day 0 · retest day 90
Damage score · retest day 90
78/100
vs baseline (day 0)
-3
2 improved · 8 worsened
synthetic signature · consistent with this patient's biology
- 5 opportunists above range: Escherichia coli, Klebsiella pneumoniae, Enterococcus faecium
- 6 keystone species absent
- Shannon 2.05 (expected ≥ 3)
- 11 resistance genes
- Tissue recycling index 55
Pathogens / opportunists5/5
↑ from 3
Keystone species6/8
↑ from 5
Diversity2/2
Metabolic modules0/4
Vitamin synthesis5/7
↑ from 4
Oral translocation1/1
Host DNA0/1
↓ from 1
Tissue recycling1/1
Central mechanisms2/2
Virulence factors6/6
↑ from 5
Antibiotic resistance genes11/11
↑ from 8
Genetic predisposition2/2
Opportunists above range
Escherichia coli 31.089% AR
Enterococcus faecium 15.544% AR
Klebsiella pneumoniae 9.327% AR
Streptococcus gallolyticus 3.109% AR
Keystone species absent
Akkermansia muciniphila, Bifidobacterium longum, Butyricicoccus pullicaecorum, Eubacterium rectale, Faecalibacterium prausnitzii
Capacity
Shannon 2.05 · butyrate 312 CPM · SCFA 615
5 vitamins below
Host & mechanisms
tissue recycling 55/100
oral translocation 7.05% AR
molecular_mimicry above
estrobolome above
11 resistance genes · 6 virulence factors
Import a sample
A baseline sample re-initializes this patient's microbiome, pathways and predispositions from the measurement; a retest adds a comparison and updates them. Every theory, steering gain and dietary sensitivity downstream is then conditioned on the measured signature.
All elements · baseline → latest
Value, status vs the expected range, and the implication on health. Changes coloured: green improved / resolved, red worsened / new.
Pathogens / opportunists · 5
| Escherichia coli | 26.821 % AR · above range | 31.089 % AR · above range | expected <= 1% | In excess raises LPS load and zonulin release, opening tight junctions. |
| Klebsiella pneumoniae | 8.046 % AR · above range | 9.327 % AR · above range | expected <= 0.3% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Enterococcus faecium | 13.41 % AR · above range | 15.544 % AR · above range | expected <= 0.5% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Streptococcus gallolyticus | 0.032 % AR · in range | 3.109 % AR · above range(worsened) | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
| Clostridioides difficile | 0.059 % AR · in range | 3.109 % AR · above range(worsened) | expected <= 0.1% | Opportunist above range; relevant after antibiotics and in inflammation. |
Keystone species · 8
| Akkermansia muciniphila | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Bifidobacterium longum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Butyricicoccus pullicaecorum | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Eubacterium rectale | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Faecalibacterium prausnitzii | 0 % AR · absent | 0 % AR · absent | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Lactobacillus species | 1.42 % AR · in range | 0 % AR · absent(worsened) | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Roseburia intestinalis | 0.3 % AR · in range | 1.32 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
| Ruminococcus bromii | 0.49 % AR · in range | 0.04 % AR · in range | expected 0.15-2.24% | Keystone butyrate producer / mucin specialist. |
Diversity · 2
| indice Shannon | 2.17 · below range | 2.05 · below range | expected >= 3.0 | Low diversity: fewer reserve metabolic routes, slower recovery after perturbation. |
| numar de specii detectate | 77 specii · below range | 70 specii · below range | expected >= 100 | Species count below reference. |
Metabolic modules · 4
| Butyrate production | 442 CPM · in range | 312 CPM · in range | expected 255.83-1089.91 CPM | Butyrate is the main colonocyte fuel and barrier signal. |
| Short Chain Fatty Acid Production | 797 CPM · in range | 615 CPM · in range | expected 535.03-1572.59 CPM | Total SCFA capacity. |
| GABA production | 218 CPM · in range | 167 CPM · in range | expected 87.31-766.53 CPM | Gut–brain axis capacity. |
| H2S production (sulfate reduction) | 108 CPM · in range | 121 CPM · in range | expected banda de referinta | Hydrogen sulfide above band irritates the mucosa. |
Vitamin synthesis · 7
| Vitamin B1 - Thiamin | 507 CPM · below range | 279 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B2 - Riboflavin | 208 CPM · below range | 406 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B5 - Pantothenic acid | 416 CPM · below range | 363 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B6 - Pyridoxine | 384 CPM · below range | 469 CPM · below range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B7 - Biotin | 2765 CPM · in range | 384 CPM · below range(worsened) | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B9 - Folate | 2952 CPM · in range | 3676 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
| Vitamin B12 - Cobalamin | 3040 CPM · in range | 4269 CPM · in range | expected 2000-5000 CPM | Microbial synthesis capacity. |
Oral translocation · 1
| Translocare orala (indice) | 6.08 % AR · above range | 7.05 % AR · above range | expected <= 2% | Oral taxa in stool: reduced gastric barrier or dysbiosis. |
Host DNA · 1
| fragmentare mixta | 237 pb · atypical | 159 pb · in range(improved) | expected 150-170 pb | Host cell-free DNA fragmentation pattern. |
Tissue recycling · 1
| indice de reciclare tisulara | 55 /100 · above range | 55 /100 · above range | expected < 35 | Epithelial turnover. |
Central mechanisms · 2
| molecular_mimicry | 76 /100 · above range | 79 /100 · above range | expected < 65 | Cross-reactive antigen load. |
| estrobolome | 71 /100 · above range | 70 /100 · above range | expected < 65 | Estrogen-recycling capacity. |
Species dominance · 1
| Bifidobacterium breve | 20.35 % AR · above range | resolved(resolved) | expected < 20% per specie | One species occupies the niche of others. |
Virulence factors · 6
| fimD outer membrane usher | 45 potriviri/M · present | 88 potriviri/M · present | expected absent | Virulence factor detected. |
| chuA heme/hemoglobin receptor | 46 potriviri/M · present | 43 potriviri/M · present | expected absent | Virulence factor detected. |
| irp2 yersiniabactin synthetase | 100 potriviri/M · present | 76 potriviri/M · present | expected absent | Virulence factor detected. |
| espX4 type III secretion | 42 potriviri/M · present | 78 potriviri/M · present | expected absent | Virulence factor detected. |
| kpsD polysialic acid transport | 77 potriviri/M · present | 95 potriviri/M · present | expected absent | Virulence factor detected. |
| acrB acriflavine resistance | — | 37 potriviri/M · present(new) | expected absent | Virulence factor detected. |
Antibiotic resistance genes · 11
| sul1 | 5.1 citiri/M · present | 10.8 citiri/M · present | expected nedetectat | Resistance gene detected. |
| sul2 | 9 citiri/M · present | 6.7 citiri/M · present | expected nedetectat | Resistance gene detected. |
| tet(O/M/O) | 7.5 citiri/M · present | 9.7 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Ecol_ampC_BLA | 4.5 citiri/M · present | 8.4 citiri/M · present | expected nedetectat | Resistance gene detected. |
| aadA | 5.4 citiri/M · present | 8.3 citiri/M · present | expected nedetectat | Resistance gene detected. |
| dfrA1 | 9 citiri/M · present | 4.3 citiri/M · present | expected nedetectat | Resistance gene detected. |
| APH(6)-Id | 7.9 citiri/M · present | 2.9 citiri/M · present | expected nedetectat | Resistance gene detected. |
| Erm(49) | 3.5 citiri/M · present | 3.4 citiri/M · present | expected nedetectat | Resistance gene detected. |
| msrC | — | 7.2 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
| eptB | — | 10.6 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
| ugd | — | 9.7 citiri/M · present(new) | expected nedetectat | Resistance gene detected. |
Genetic predisposition · 2
| FUT2 | 1.6 OR · risk variant | 2.09 OR · risk variant | expected reference genotype | Reduced mucosal fucosylation |
| IL6 | 3.05 OR · risk variant | 3.19 OR · risk variant | expected reference genotype | Higher inflammatory tone |